BC Study to Pave the Way for Tailored Treatment of Depression
Genome BC Blog
by Brad Lyle
2w ago
A new research initiative in British Columbia is exploring ways for the BC healthcare system to tailor depression treatments to the unique needs of each person, moving towards a more effective and patient-centred approach. “Depression is very common. In Canada, more than 1 in 10 people will suffer a form of major depression at some point in their lives,” says Dr. Jehannine (J9) Austin, a professor of medical genetics and psychiatry at the University of British Columbia and one of the project co-leaders, which is funded by Genome British Columbia (Genome BC). “Drug therapies are one of the main ..read more
Visit website
Genome BC Welcomes Dr. Mel Krajden to its Board of Directors, Announces New Board Leadership
Genome BC Blog
by Brad Lyle
3w ago
Genome British Columbia is pleased to announce the appointment of Dr. Mel Krajden to our Board of Directors   Dr. Mel Krajden is a Medical Microbiologist researcher at the BC Centre for Disease Control (BCCDC). He is the former Medical Director of the BCCDC Public Health Laboratory and Medical Head of Hepatitis at BCCDC. He is also a professor in the UBC Department of Pathology and Laboratory Medicine. Dr. Krajden is considered a world leader in infectious disease epidemiology and phylogenetics research, focusing on translating research into public health policy. Dr. Krajden has received ..read more
Visit website
Precision matching for kidney transplants: BC project targets reduced rejections and elimination of need for lifelong medication
Genome BC Blog
by Brad Lyle
1M ago
British Columbia has been selected as the test bed for a potentially game-changing genomics project to improve kidney transplant outcomes across Canada in partnership with Canadian Blood Services — the national coordinator of transplant services. This project, funded by Genome British Columbia, Genome Canada, Michael Smith Health Research BC, Vancouver Coastal Health Research Institute and others, seeks to significantly reduce organ rejection rates, improve patient outcomes and save millions of dollars in healthcare costs. Dr. Paul Keown is a specialist in immunology and transplantation, a pr ..read more
Visit website
Understanding the Genetics of Schizophrenia 
Genome BC Blog
by Sarah Lando
1M ago
In the last 15 years, scientists have made big strides in understanding the genetics of schizophrenia. They’ve found that it’s not caused by just one gene, but by many genes working together, some common and some rare.   These genes affect how brain cells communicate with each other, and they’re linked to other conditions like bipolar disorder and childhood developmental disorders.  However, even with all this progress, we still don’t have all the answers. Current genetic methods can only explain about 40% of the heritability of schizophrenia. This makes it tough to understand exactl ..read more
Visit website
Exploring Living Innovations: Insights from Genome BC’s Annual Genomics Forum 2024
Genome BC Blog
by Sarah Lando
2M ago
Genome BC’s Annual Genomics Forum 2024, themed “Living Innovations: BC’s Path to Biological Engineering,” brough together experts from diverse sectors such as life sciences, business and industry. Kicking off the event, Suzanne Gill, Genome BC’s President and Chief Executive Officer, underscored the forum’s theme of exploring the potential of genome engineering to tackle issues in health, bioproduct development and conservation. She highlighted how genome engineering enables precise modifications to the DNA blueprint, paving the way for disease-resistant crops, novel medicines and other innova ..read more
Visit website
Policy foresight: a valuable tool in an era of rapid technological change
Genome BC Blog
by A.G. Klei
2M ago
This following article was originally published by Re$earch Money. Policy and decision makers face a growing challenge: keeping up with the ever-increasing complexity and rapid pace of development in cutting-edge technologies. The speed of innovation, combined with so many variables and often competing priorities, makes it difficult to plan for the future. Facilitating the development of new tools, and the uptake of existing ones, often requires a variety of policies. It can be a cumbersome and complicated process fraught with risks and uncertainty. The field of genomics, the study of the ..read more
Visit website
From Poop to Proof: GEMSTONE Project Aims to Flush Out Source of Marine Fecal Pollution
Genome BC Blog
by A.G. Klei
3M ago
Highlights Current surveillance methods in British Columbia’s (BC) marine waters detect fecal contamination in shellfish harvesting areas but fail to identify its source or type, which may lead to prolonged closures of shellfish harvesting areas The GEMSTONE project, led by UBC and BCCDC researchers, aims to improve pollution monitoring by developing genomic methods to pinpoint contamination sources By empowering communities with precision testing and early-warning systems, GEMSTONE seeks to safeguard public health and the viability of BC’s shellfish industry against costly outbreaks   ..read more
Visit website
Introducing Wes Peterson, Genome BC’s New Vice President, Corporate Development
Genome BC Blog
by Brad Lyle
4M ago
Genome BC is delighted to announce the hiring of Wes Peterson as Vice President, Corporate Development. With a distinguished career spanning over two decades, Wes brings a wealth of experience in finance, research, management and strategic leadership to our organization. Wes Peterson, Genome BC’s New Vice President, Corporate Development Wes joins us from the BC Beverage Technology Access Centre, where he served as General Manager for the last five years.  Wes helped launch and lead the Centre to support applied research, development and innovation for the Canadian beverage sector. Prio ..read more
Visit website
Genome BC Welcomes Steven Zicherman to its Board of Directors
Genome BC Blog
by Brad Lyle
5M ago
Genome British Columbia is pleased to announce the appointment of Steven Zicherman to our Board of Directors   Steven Zicherman, Director and Equity Analyst at Odlum Brown Limited, has been appointed to Genome BC’s Board of Directors. Steven Zicherman is an Equity Analyst at Odlum Brown Limited. He has over 20 years of experience providing analytical coverage for various market sectors, including information technology and health care. Mr. Zicherman has a Bachelor of Arts degree in Statistics from the University of Western Ontario, an MBA from Dalhousie University and is a Chartered Fin ..read more
Visit website
The Fatally Urgent Need for Genetically Diverse Biobanks
Genome BC Blog
by Sarah Lando
5M ago
In 2009, Time Magazine predicted that Biobanks would be among the top ten technologies to change the world. But what exactly are they?  What are Biobanks and Why do they Matter?     As Time Magazine put it, a biobank is like an “organic bank account” that collects and stores biological samples, such as tissue and blood, as well as health data, lifestyle information and medication details – creating a genomic database. The collected biomaterial and health data are like a bank deposit. Researchers then use biobanks to access samples, collect data and conduct studies generating a t ..read more
Visit website

Follow Genome BC Blog on FeedSpot

Continue with Google
Continue with Apple
OR